MiRNALet‐7a mediates prostate cancer PC‐3 cell invasion, migration by inducing epithelial‐mesenchymal transition through CCR7/MAPK pathway
- 9 January 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (4) , 3725-3731
Abstract
Prostate cancer is one of the most common malignancies in older men. Recent evidence has demonstrated microRNA (miRNA) Let‐7a expression decreased in prostate cancer, while the expression of CC chemokine receptor type 7 (CCR7) increased. In this study, we investigated whether CCR7 overexpression was associated with a decrease in the expression of miRNA Let‐7a in invasion and metastasis of prostate cancer cell. Synthetic Let‐7a mimics and Let‐7a inhibitors were transfected into prostate cancer PC‐3 cells, respectively. Then Western blot was used to detect the expression of CCR7, ERK, p38, MMP‐9, and Epithelial‐Mesenchymal Transition (EMT)‐related proteins. Matrigel invasion assays were performed to assess the migratory and invasive activities of PC3 cells. To confirm the fact that 3′UTR of CCR7 is a direct target of Let‐7a, a luciferase assay for the reporter gene expressing the Let‐7a binding sites of CCR7 3′UTR was used. Synthetic Let‐7a mimics decreased prostate cancer cell migration and invasion, as well as the expression of CCR7, phospho‐p38, phospho‐ERK1/2, MMP‐9, N‐cadherin, and Snail in PC‐3 cells. The Let‐7a inhibitors reversed the effects of Let‐7a on PC‐3 cells. The 3′UTR of CCR7 was confirmed as a direct target of Let‐7a by using the luciferase assay. All findings demonstrated that Let‐7a/CCR7 axis regulated EMT progress in prostate cancer cells and mediated the tumor cell invasion and migration process via activation of P38/ERK signal pathway. Our results suggested that the therapeutic potential of Let‐7a as an antitumor and antimetastatic manager in prostate cancer and CCR7 may be regarded as a therapeutic target for the prostate cancer treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81302237)
- Chongqing Municipal Science and Technology Bureau (cstc2016jcyjA0864)
This publication has 29 references indexed in Scilit:
- Micro-RNAs as diagnostic or prognostic markers in human epithelial malignanciesBMC Cancer, 2011
- NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNACancer Letters, 2011
- MicroRNA Expression and Clinical Outcome of Small Cell Lung CancerPLOS ONE, 2011
- MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferationMolecular Cancer, 2010
- Many new down‐ and up‐regulatory signaling pathways, from known cancer progression suppressors to matrix metalloproteinases, differ widely in cells of various cancersJournal of Cellular Physiology, 2010
- MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2PLOS ONE, 2010
- Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7The EMBO Journal, 2009
- Chemokine Receptor CCR7 Expression Correlates with Lymph Node Metastasis in Pancreatic CancerOncology, 2008
- let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer CellsCell, 2007
- Researchers Tackle Metastasis, Cancer's Last FrontierJNCI: Journal of the National Cancer Institute, 2007